Clinical Trial: Case Series : Management of Elevated Lipoprotein(a) Using Double-Filtration Plasmapheresis (DFPP) in Hemodialysis Patients With Chronic Kidney Disease ; ( LiPo-A )

U.S., Feb. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07390604) titled 'Case Series : Management of Elevated Lipoprotein(a) Using Double-Filtration Plasmapheresis (DFPP) in Hemodialysis Patients With Chronic Kidney Disease ; ( LiPo-A )' on Jan. 14.

Brief Summary: Lipoprotein-apheresis DFPP has been performed in patients with Lp(a) levels greater than 125 nmol/L. In this report, data will be presented on five hemodialysis patients with significantly elevated Lp(a) levels (>200 nmol/L) who had a history of cardiovascular disease and notable thromboembolic events.

Study Start Date: July 01, 2025

Study Type: OBSERVATIONAL

Condition: Lipoprotein(a) Lipoprotein-apheresis Double-filtration Plasmapheresis He...